The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceuticals market was valued at US$ 6761 million in 2023 and is anticipated to reach US$ 11660 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals.
Report Scope
The Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
Segment by Type
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
Segment by Application
- Oncology
- Cardiology
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Radiopharmaceuticals
1.2 Radiopharmaceuticals Segment by Type
1.2.1 Global Radiopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Radiopharmaceuticals Segment by Application
1.3.1 Global Radiopharmaceuticals Market Value by Application: (2024-2030)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceuticals Revenue 2019-2030
1.4.2 Global Radiopharmaceuticals Sales 2019-2030
1.4.3 Global Radiopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Radiopharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiopharmaceuticals, Product Type & Application
2.7 Radiopharmaceuticals Market Competitive Situation and Trends
2.7.1 Radiopharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Radiopharmaceuticals Players Market Share by Revenue
2.7.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Radiopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Radiopharmaceuticals Global Radiopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Radiopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Radiopharmaceuticals Sales by Region: 2025-2030
3.3 Global Radiopharmaceuticals Global Radiopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Radiopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Radiopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Radiopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Radiopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Radiopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Radiopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Radiopharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Radiopharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Radiopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Radiopharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Radiopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Radiopharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Radiopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Radiopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Radiopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Radiopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Radiopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Radiopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Radiopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Radiopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Radiopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Radiopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Radiopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Radiopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Radiopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Radiopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Radiopharmaceuticals Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Nordion
6.4.1 Nordion Corporation Information
6.4.2 Nordion Description and Business Overview
6.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nordion Radiopharmaceuticals Product Portfolio
6.4.5 Nordion Recent Developments/Updates
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporation Information
6.5.2 Triad Isotopes Description and Business Overview
6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio
6.5.5 Triad Isotopes Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lantheus Radiopharmaceuticals Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 IBA Group
6.6.1 IBA Group Corporation Information
6.6.2 IBA Group Description and Business Overview
6.6.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IBA Group Radiopharmaceuticals Product Portfolio
6.7.5 IBA Group Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporation Information
6.9.2 China Isotope & Radiation Description and Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio
6.9.5 China Isotope & Radiation Recent Developments/Updates
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporation Information
6.10.2 Jubilant Pharma Description and Business Overview
6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio
6.10.5 Jubilant Pharma Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Radiopharmaceuticals Description and Business Overview
6.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporation Information
6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Description and Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio
6.12.5 Advanced Accelerator Applications Recent Developments/Updates
6.13 SIEMENS
6.13.1 SIEMENS Corporation Information
6.13.2 SIEMENS Radiopharmaceuticals Description and Business Overview
6.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.13.4 SIEMENS Radiopharmaceuticals Product Portfolio
6.13.5 SIEMENS Recent Developments/Updates
6.14 Dongcheng
6.14.1 Dongcheng Corporation Information
6.14.2 Dongcheng Radiopharmaceuticals Description and Business Overview
6.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Dongcheng Radiopharmaceuticals Product Portfolio
6.14.5 Dongcheng Recent Developments/Updates
6.15 Navidea
6.15.1 Navidea Corporation Information
6.15.2 Navidea Radiopharmaceuticals Description and Business Overview
6.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Navidea Radiopharmaceuticals Product Portfolio
6.15.5 Navidea Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiopharmaceuticals Industry Chain Analysis
7.2 Radiopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiopharmaceuticals Production Mode & Process
7.4 Radiopharmaceuticals Sales and Marketing
7.4.1 Radiopharmaceuticals Sales Channels
7.4.2 Radiopharmaceuticals Distributors
7.5 Radiopharmaceuticals Customers
8 Radiopharmaceuticals Market Dynamics
8.1 Radiopharmaceuticals Industry Trends
8.2 Radiopharmaceuticals Market Drivers
8.3 Radiopharmaceuticals Market Challenges
8.4 Radiopharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
